<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Am J Hum Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Hum. Genet</journal-id>
<journal-title-group>
<journal-title>American Journal of Human Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0002-9297</issn>
<issn pub-type="epub">1537-6605</issn>
<publisher>
<publisher-name>Elsevier</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27839871</article-id>
<article-id pub-id-type="pmc">5142120</article-id>
<article-id pub-id-type="publisher-id">S0002-9297(16)30438-4</article-id>
<article-id pub-id-type="doi">10.1016/j.ajhg.2016.10.002</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Swanger</surname>
<given-names>Sharon A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Wenjuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="fn" rid="fn1">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wells</surname>
<given-names>Gordon</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="fn" rid="fn2">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Burger</surname>
<given-names>Pieter B.</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tankovic</surname>
<given-names>Anel</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bhattacharya</surname>
<given-names>Subhrajit</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Strong</surname>
<given-names>Katie L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Chun</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kusumoto</surname>
<given-names>Hirofumi</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adams</surname>
<given-names>David R.</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Millichap</surname>
<given-names>John J.</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Petrovski</surname>
<given-names>Slavé</given-names>
</name>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Traynelis</surname>
<given-names>Stephen F.</given-names>
</name>
<email>strayne@emory.edu</email>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff6">6</xref>
<xref ref-type="corresp" rid="cor1">∗</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yuan</surname>
<given-names>Hongjie</given-names>
</name>
<email>hyuan@emory.edu</email>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff6">6</xref>
<xref ref-type="corresp" rid="cor2">∗∗</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA</aff>
<aff id="aff2"><label>2</label>Department of Chemistry, Emory University, Atlanta, GA 30322, USA</aff>
<aff id="aff3"><label>3</label>Undiagnosed Diseases Network, National Human Genome Research Institute, NIH, Bethesda, MD 20892, USA</aff>
<aff id="aff4"><label>4</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine and Ann &amp; Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL 60611, USA</aff>
<aff id="aff5"><label>5</label>Department of Medicine, The University of Melbourne, Austin Health and Royal Melbourne Hospital, Melbourne, VIC 3050, Australia</aff>
<aff id="aff6"><label>6</label>Center for Functional Evaluation of Rare Variants (CFERV), Emory University School of Medicine, Atlanta, GA 30322, USA</aff>
<author-notes>
<corresp id="cor1"><label>∗</label>Corresponding author <email>strayne@emory.edu</email></corresp>
<corresp id="cor2"><label>∗∗</label>Corresponding author <email>hyuan@emory.edu</email></corresp>
<fn id="fn1">
<label>7</label>
<p id="ntpara0010">Present address: Department of Neurology, Xiangya Hospital, Central South University, Changsha 410013, China</p>
</fn>
<fn id="fn2">
<label>8</label>
<p id="ntpara0015">Present address: Department of Biochemistry, Stellenbosch University, Stellenbosch 7602, South Africa</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>11</month>
<year>2016</year>
</pub-date>
<volume>99</volume>
<issue>6</issue>
<fpage>1261</fpage>
<lpage>1280</lpage>
<history>
<date date-type="received">
<day>20</day>
<month>8</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>3</day>
<month>10</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2016 American Society of Human Genetics.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>American Society of Human Genetics</copyright-holder>
</permissions>
<abstract id="abs0010">
<p>Epilepsy and intellectual disability are associated with rare variants in the GluN2A and GluN2B (encoded by <italic>GRIN2A</italic> and <italic>GRIN2B</italic>) subunits of the <italic>N</italic>-methyl-<italic>D</italic>-aspartate receptor (NMDAR), a ligand-gated ion channel with essential roles in brain development and function. By assessing genetic variation across GluN2 domains, we determined that the agonist binding domain, transmembrane domain, and the linker regions between these domains were particularly intolerant to functional variation. Notably, the agonist binding domain of GluN2B exhibited significantly more variation intolerance than that of GluN2A. To understand the ramifications of missense variation in the agonist binding domain, we investigated the mechanisms by which 25 rare variants in the GluN2A and GluN2B agonist binding domains dysregulated NMDAR activity. When introduced into recombinant human NMDARs, these rare variants identified in individuals with neurologic disease had complex, and sometimes opposing, consequences on agonist binding, channel gating, receptor biogenesis, and forward trafficking. Our approach combined quantitative assessments of these effects to estimate the overall impact on synaptic and non-synaptic NMDAR function. Interestingly, similar neurologic diseases were associated with both gain- and loss-of-function variants in the same gene. Most rare variants in GluN2A were associated with epilepsy, whereas GluN2B variants were associated with intellectual disability with or without seizures. Finally, discerning the mechanisms underlying NMDAR dysregulation by these rare variants allowed investigations of pharmacologic strategies to correct NMDAR function.</p>
</abstract>
</article-meta>
<notes>
<p id="misc0010">Published: November 10, 2016</p>
</notes>
</front>
</article>
</pmc-articleset>